The single use filtration assemblies market has seen considerable growth due to a variety of factors.
•The market size of single-use filtration assemblies has seen a swift expansion in the last few years. Projected growth sees it moving from $4.92 billion in 2024 to $5.6 billion in 2025, marking a compound annual growth rate (CAGR) of a significant 13.9%.
Factors contributing to this historic period growth include a surge in biopharmaceutical production, rigorous regulatory standards, cost-effectiveness in bioprocessing, and a decreased likelihood of cross-contamination.
The single use filtration assemblies market is expected to maintain its strong growth trajectory in upcoming years.
• The market for single use filtration assemblies is projected to experience swift expansion in the coming years, with its value expected to reach $10.18 billion in 2029, reflecting a compound annual growth rate (CAGR) of 16.1%.
This growth during the forecast period can be linked to the expansion of biomanufacturing capacity, a dedication to sustainability, adaptability in manufacturing procedures, and a rise in bioprocess outsourcing. Continuous bioprocessing, risk regulation and adherence, the incorporation of intelligent technologies, emphasis on high-value biologics, and outsourcing trends are anticipated to be the main trends in this period.
The surge in research and development funding from biopharmaceutical companies is accelerating the growth of the single-use filtration assemblies market. The concept of pharmaceutical research and development encompasses the discovery, enhancement, and development of new medicines through rigorous scientific studies and trials. Single-use filtration assemblies are instrumental in the production research and development of a variety of biopharmaceuticals, as they eliminate cells and debris from the vessels. A notable rise in global investment in research and development by biopharmaceutical companies has stimulated market expansion. For instance, in September 2022, the UK government disclosed its research and development expenditure for pharmaceuticals for 2022-2025 to be $49.2 Billion (£39.8 bn). In January 2023, Roche Holding AG, a Switzerland-based biopharmaceuticals producer, revealed a 3.7% increase in its R&D spending in 2022 compared to 2021. Similarly, in March 2023, Merck, a German biopharmaceuticals producer, disclosed a 3.9% rise in its R&D investment in 2022 compared to 2021. Therefore, the heightened investment in R&D by biopharmaceutical companies is fuelling the growth of the single-use filtration assemblies market.
The single use filtration assemblies market covered in this report is segmented –
1) By Type: Membrane Filtration, Depth Filtration, Centrifugation, Other Types
2) By Product: Filters, Cartridges, Membranes, Manifold, Cassettes, Syringes, Other Products
3) By Application: Pharmaceuticals Manufacturing market, Bioprocessing Or Biopharmaceuticals market, Laboratory Use
Subsegments:
1) By Membrane Filtration: Microfiltration Membranes, Ultrafiltration Membranes, Nanofiltration Membranes, Reverse Osmosis Membranes
2) By Depth Filtration: Cellulose Depth Filters, Polymer Depth Filters, Glass Fiber Depth Filters
3) By Centrifugation: Single-Use Centrifuge Systems, Rotors For Centrifugation, Collection Containers For Centrifugation
4) By Other Types: Tangential Flow Filtration (TFF), Filtration Skids, Single-Use Filtration Cartridges
One of the main trends gaining traction in the single-use filtration assembly market is product innovation. Key players in the single-use filtration assembly market are introducing new improvements to maintain their market stance. For instance, in September 2022, Thermo Fisher Scientific, a company based in the US that manufactures medical equipment and scientific instruments, launched the DynaSpin Single-Use Centrifugal system. This innovative product transforms and simplifies cell culture separation in single-use bioprocesses by cutting down the need for multiple depth filtration cartridges during the collection phase. What sets this product apart is its ability to reduce waste by 70% compared to conventional harvesting methods.
Major companies operating in the single use filtration assemblies market include:
• Thermo Fisher Scientific Inc.
• 3M Company
• Danaher Corporation
• Merck KGaA
• Asahi Kasei Corporation
• Eaton Corporation
• GE Healthcare
• Parker Hannifin Corporation
• MilliporeSigma
• Avantor Inc.
• Alfa Laval AB
• Steris Corporation
• Sartorius AG
• Donaldson Company Inc.
• Pall Corporation
• Entegris Inc.
• Filtration Group Corporation
• GVS Filter Technology
• Meissner Filtration Products Inc.
• Porvair Filtration Group
• Graver Technologies
• Sterlitech Corporation
• Alpha Plan GmbH
• Amazon Filters Ltd.
• Dr. Mueller AG
• Axiva Sichem Pvt. Ltd.
• UltraPure International B.V.
• Advantec MFS Inc.
North America was the largest region in the single use filtration assemblies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single use filtration assemblies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.